Brian J. Lynch

Former Senior Vice President and General CounselatMadrigal Pharmaceuticals· In proxies 2021–2024

Pay in FY2024-19% from the year before · Madrigal Pharmaceuticals stock +33.4% the same year

Brian J. Lynch was paid $4.3M in FY2024 (Dec), down 19%. Madrigal Pharmaceuticals stock rose 33.4% that year.

Pay$100 in the stock at the end of FY20 → $278

Pay is from the Summary Compensation Table of each Madrigal Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

MDGL
Madrigal PharmaceuticalsPublic company · 5 yr
- Former Senior Vice President and General Counsel2021 – Present · 5 yrStock in role +259%

Roles come from the proxy statements of each company.

Activity

Pay
Madrigal Pharmaceuticals General counsel pay fell 19% to $4.3M. The stock rose 33% in FY2024 (Dec).
DEF 14AApr 29, 2025
Pay
Madrigal Pharmaceuticals General counsel pay rose 39% to $4.8M. The stock rose 243% in FY2022 (Dec).
DEF 14AApr 29, 2025
Pay
Madrigal Pharmaceuticals General counsel pay rose 11% to $5.3M. The stock fell 20% in FY2023 (Dec).
DEF 14AApr 29, 2024

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?